TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a roundup of comments from its reporters on October 18, 2026, covering eight health and medicine topics. The quotes include cautions about AI’s effects, access to a new mRNA flu shot, and how to interpret findings on medication safety, transplantation and cancer risk.
MedPage Today published a weekly roundup on October 18 featuring comments from researchers and clinicians on eight health-related topics, from artificial intelligence in health care to pediatric obesity screening. The collection is a snapshot of remarks tied to reporting and research, not a single study or policy announcement.
The roundup opens with Mishal Khan, PhD, of the UC Berkeley Labor Center, reflecting on artificial intelligence in health care: “Tech is not good or bad, but neither is it neutral.” The remark frames technology as something whose effects depend on how it is developed and used, rather than as an inherently beneficial or harmful tool.
Other comments address access to mFlusiva, described in the source as a new mRNA flu shot; plastic surgery and the early-2000s reality show “The Swan”; and a study of benzodiazepine use early in pregnancy. Krista Huybrechts, MS, PhD, of Brigham and Women’s Hospital called the study’s findings “reassuring,” while adding that benzodiazepines “are not risk-free.”
The remaining remarks concern how to interpret pulmonary vascular resistance after heart transplantation, possible cancer risk among people with sickle cell disease, long-acting HIV therapy, and screening for pediatric obesity. The source attributes the comments to named experts but does not provide full study descriptions, methods, or links to the underlying research within the supplied roundup.
Eight Topics, One Cautious Thread
The roundup brings several distinct medical conversations into one place, while its short quotations also show the limits of reading research findings in isolation. Access, risk and interpretation recur across the comments: who can obtain a treatment, what a study can establish, and which patient details matter beyond a single measure.
Khan’s observation about AI is relevant to health systems weighing technology because it points to the importance of deployment choices and their effects. The other comments likewise urge care in drawing broad conclusions: Huybrechts pairs reassurance with a risk caveat, and Ahmed Zayed says pulmonary vascular resistance should not be read alone. These are expert perspectives reported by MedPage Today, not findings established by the quotes themselves.
Products Worth Considering
Withings BPM Connect Smart Blood Pressure Monitor
Withings BPM Vision Blood Pressure Monitor with Wi-Fi and Bluetooth
LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
The Reporting Behind the Quotes
MedPage Today describes the item as “Quotable quotes heard by MedPage Today’s reporters” and dates it October 18, 2026. Its format gathers brief remarks associated with separate stories, rather than presenting a unified investigation or a new set of results. The comments cover clinical care, research interpretation, health technology and public access.
That distinction matters when interpreting the collection. A quote may summarize an expert’s view of a study, but the roundup alone does not supply the study’s design, population, results or limitations. For example, the source gives no numerical findings for the pregnancy medication or transplantation research. The quotations can identify questions raised in the reporting, but readers would need the original studies or full articles to evaluate the evidence.
““Tech is not good or bad, but neither is it neutral.””
— Mishal Khan, PhD, UC Berkeley Labor Center
What the Roundup Leaves Open
The supplied roundup does not include the underlying reports or enough detail to assess the evidence behind each comment. Study methods, sample sizes and numerical results are not provided for the research on pregnancy medication, transplantation, sickle cell disease, HIV therapy or obesity screening.
It is also unclear from the source what website or contact route is required to obtain mFlusiva, who is eligible, or where it is available. The AI comment does not identify a specific system or measured effect. The roundup presents expert remarks, but does not establish that the views represent consensus among clinicians or researchers.
Follow the Linked Research and Access Details
The next step for readers seeking evidence is to consult the full MedPage Today stories and the studies discussed there. Those materials would clarify the research designs and findings behind the quoted comments, including the populations studied and the limits researchers identified.
For mFlusiva, readers will need current information from the relevant provider or official product and public health sources about availability and access routes. The roundup itself announces no new release date, regulatory action or follow-up study, so further developments on those points are not specified in the source.
Key Questions
What did MedPage Today publish?
It published a weekly collection of expert comments from its reporters on October 18, 2026. The remarks cover eight health and medicine topics.
Is the roundup a new research study?
No. It is a quotes roundup tied to separate reporting and research topics, not a study or a single policy announcement.
What did the roundup say about AI in health care?
Mishal Khan of the UC Berkeley Labor Center said, “Tech is not good or bad, but neither is it neutral.” The roundup does not identify a particular AI product or report measured outcomes.
What is known about mFlusiva access?
Amesh Adalja said people seeking mFlusiva would need to use a website or call around. The supplied source does not state where it is available, who qualifies or which website to use.
Do the quotes provide enough detail to assess the studies?
No. The roundup gives short comments but not the full study methods, results or limitations. Readers need the linked reporting or original research for those details.
Source: rss
